Nevertheless, IDO2 is expressed at high levels in some human tumors and, therefore, understanding its true function/s in neoplastic contexts may propel the development of new drugs targeting enzymes of the kynurenine pathway in cancer immunotherapy. Here, IDO2 is linked to cancer.